← Open Payments lookup

STACEY WRIGHT: Open Payments

NPI 1497716476 · GARDEN CITY, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,188 in 33 payments from 12 companies in 2025. Trend: 2023 $1,770 · 2024 $639 · 2025 $1,188

Food & beverage: $1,188
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.8$200
Neurocrine BioSciences, Inc.3$178
Teva Pharmaceuticals USA, Inc.4$169
E.R. Squibb & Sons, L.L.C.3$156
Janssen Pharmaceuticals, Inc2$138
ABBVIE INC.3$136
Vanda Pharmaceuticals Inc.3$67
Axsome Therapeutics, Inc.3$57
Takeda Pharmaceuticals U.S.A., Inc.1$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24

Products named: INGREZZA, COBENFY, VRAYLAR, SPRAVATO, UZEDY, ABILIFY MAINTENA, REXULTI, FANAPT.

Industry payments across ID — which companies pay providers there.